Concord Medical Services (CCM)
(Delayed Data from NYSE)
$0.66 USD
-0.01 (-2.02%)
Updated May 28, 2024 11:25 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CCM 0.66 -0.01(-2.02%)
Will CCM be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CCM based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CCM
Mortgage rates dropped below 7% for 1st time in more than a month
Mortgage rates drop below 7% for 1st time in more than a month
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Mortgage rates fall for 2nd consecutive week in wake of eased inflation report
Mortgage rates decline after 5 weeks of gain in wake of weak jobs report